CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,829 | +35.3% | 47,595 | -18.5% | 0.00% | 0.0% |
Q1 2023 | $1,352 | -26.4% | 58,421 | -16.7% | 0.00% | -33.3% |
Q4 2022 | $1,837 | -99.9% | 70,116 | +11.5% | 0.00% | +50.0% |
Q3 2022 | $1,236,000 | +13.9% | 62,875 | +1.4% | 0.00% | +100.0% |
Q2 2022 | $1,085,000 | +117.9% | 62,013 | +103.7% | 0.00% | 0.0% |
Q1 2022 | $498,000 | +18.3% | 30,448 | +17.8% | 0.00% | – |
Q4 2021 | $421,000 | +68.4% | 25,842 | +31.8% | 0.00% | – |
Q3 2021 | $250,000 | -34.6% | 19,602 | -27.6% | 0.00% | – |
Q2 2021 | $382,000 | +108.7% | 27,082 | +129.9% | 0.00% | – |
Q1 2021 | $183,000 | -2.1% | 11,779 | 0.0% | 0.00% | – |
Q4 2020 | $187,000 | – | 11,779 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 5 | $0 | 0.00% |